{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T21:19:40Z","timestamp":1692652780286},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"LEO Pharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13555-020-00419-2","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T09:03:50Z","timestamp":1597223030000},"page":"1111-1120","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Calcipotriol\/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5\u201315% and PGA\u2009\u2265\u20093: Post-Hoc Analysis From Three Randomized Controlled Trials"],"prefix":"10.1007","volume":"10","author":[{"given":"Lars","family":"Iversen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merle","family":"Kurvits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja Marieke","family":"Snel-Prent\u00f8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Menter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"419_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","volume":"60","author":"A Menter","year":"2009","unstructured":"Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60:643\u201359.","journal-title":"J Am Acad Dermatol."},{"key":"419_CR2","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","volume":"80","author":"CA Elmets","year":"2019","unstructured":"Elmets CA, Leonardi CL, Davis DMR, et al. Joint AAD\u2013NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80:1073\u2013113.","journal-title":"J Am Acad Dermatol."},{"key":"419_CR3","doi-asserted-by":"crossref","unstructured":"Balato N, Napolitano M, Ayala F, et al. Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. World J Gastroenterol. 2015;21:6892\u20137.","DOI":"10.3748\/wjg.v21.i22.6892"},{"key":"419_CR4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.autrev.2014.01.008","volume":"13","author":"SK Raychaudhuri","year":"2014","unstructured":"Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmunity Rev. 2014;13:490\u20135.","journal-title":"Autoimmunity Rev."},{"key":"419_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80:1029\u201372.","journal-title":"J Am Acad Dermatol."},{"key":"419_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s13555-016-0125-6","volume":"6","author":"M Lind","year":"2016","unstructured":"Lind M, Nielsen KT, Schefe LH, et al. Supersaturation of calcipotriene and betamethasone dipropionate in a novel aerosol foam formulation for topical treatment of psoriasis provides enhanced bioavailability of the active ingredients. Dermatol Ther. 2016;6:413\u201325.","journal-title":"Dermatol Ther."},{"key":"419_CR7","unstructured":"Electronic medicines compendium (EMC). Enstilar cutaneous foam\u2014summary of product characteristics. 2018. https:\/\/www.medicines.org.uk\/emc\/product\/2139. Accessed 6 Dec 2018."},{"key":"419_CR8","unstructured":"US Food and Drug Administration. Enstilar\u2014prescribing information. 2018. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/207589s001lbl.pdf. Accessed 6 Dec 2018."},{"key":"419_CR9","first-page":"1468","volume":"14","author":"C Leonardi","year":"2015","unstructured":"Leonardi C, Bagel J, Yamauchi P, et al. Efficacy and safety of calcipotriene plus betamethasone dipropionate aerosol foam in patients with psoriasis vulgaris\u2013a randomized phase III study (PSO-FAST). J Drugs Dermatol. 2015;14:1468\u201377.","journal-title":"J Drugs Dermatol."},{"key":"419_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/jdv.13859","volume":"31","author":"C Paul","year":"2017","unstructured":"Paul C, Stein Gold L, Cambazard F, et al. Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study. J Eur Acad Dermatol Venereol. 2017;31:119\u201326.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"419_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/09546634.2015.1083935","volume":"27","author":"J Koo","year":"2016","unstructured":"Koo J, Tyring S, Werschler WP, et al. Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris\u2014a randomized phase II study. J Dermatolog Treat. 2016;27:120\u20137.","journal-title":"J Dermatolog Treat."},{"key":"419_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2147\/CCID.S180698","volume":"11","author":"A Pinter","year":"2018","unstructured":"Pinter A, Thormann H, Angeletti F, Jalili A. Calcipotriol\/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature. Clin Cosmet Investig Dermatol. 2018;11:451\u20139.","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"419_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1159\/000486700","volume":"233","author":"S Gerdes","year":"2017","unstructured":"Gerdes S, Krakor M, Anger T, Hutt HJ, Korber A. Prospective, observational, non-interventional, multicentre study on the efficacy and tolerability of a new calcipotriol\/betamethasone aerosol foam (Enstilar\u00ae) in patients with plaque psoriasis under daily practice conditions. Dermatology. 2017;233:425\u201334.","journal-title":"Dermatology"},{"key":"419_CR14","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/jdv.15488","volume":"33","author":"L Gallo","year":"2019","unstructured":"Gallo L, Megna M, Cirillo T, et al. Psoriasis and skin pain: real-life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation. J Eur Acad Dermatol Venereol. 2019;33:1312\u20135.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"419_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/2229-5178.209622","volume":"8","author":"R Torsekar","year":"2017","unstructured":"Torsekar R, Gautam MM. Topical therapies in psoriasis. Indian Dermatol Online J. 2017;8:235\u201345.","journal-title":"Indian Dermatol Online J."},{"key":"419_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/bjd.17689","volume":"181","author":"KF Hjuler","year":"2019","unstructured":"Hjuler KF, Iversen L, Rasmussen MK, Kofoed K, Skov L, Zachariae C. Localization of treatment-resistant areas in patients with psoriasis on biologics. Br J Dermatol. 2019;181:332\u20137.","journal-title":"Br J Dermatol."},{"key":"419_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/1203475415597094","volume":"20","author":"V Taraska","year":"2016","unstructured":"Taraska V, Tuppal R, Olesen M, Bang Pedersen C, Papp K. A novel aerosol foam formulation of calcipotriol and betamethasone has no impact on HPA axis and calcium homeostasis in patients with extensive psoriasis vulgaris. J Cutan Med Surg. 2016;20:44\u201351.","journal-title":"J Cutan Med Surg."},{"issue":"Suppl 4","key":"419_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1468-3083.2011.04060.x","volume":"25","author":"A Bewley","year":"2011","unstructured":"Bewley A, Page B. Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol. 2011;25(Suppl 4):9\u201314.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"419_CR19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/archderm.140.4.408","volume":"140","author":"SS Zaghloul","year":"2004","unstructured":"Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140:408\u201314.","journal-title":"Arch Dermatol."},{"key":"419_CR20","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/archderm.143.9.1175","volume":"143","author":"EM Seston","year":"2007","unstructured":"Seston EM, Ashcroft DM, Griffiths CE. Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis. Arch Dermatol. 2007;143:1175\u20139.","journal-title":"Arch Dermatol."},{"key":"419_CR21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/jdv.15398","volume":"33","author":"AE Pink","year":"2019","unstructured":"Pink AE, Jalili A, Berg P, et al. Rapid onset of action of calcipotriol\/betamethasone dipropionate cutaneous foam in psoriasis, even in patients with more severe disease. J Eur Acad Dermatol Venereol. 2019;33:1116\u201323.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"Suppl 3","key":"419_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1468-3083.2012.04525.x","volume":"26","author":"S Devaux","year":"2012","unstructured":"Devaux S, Castela A, Archier E, et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26(Suppl 3):61\u20137.","journal-title":"J Eur Acad Dermatol Venereol."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00419-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-020-00419-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00419-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T23:09:24Z","timestamp":1628723364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-020-00419-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1007\/s13555-020-00419-2","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"15 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}